XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 10,828,656 $ 10,426,249
Investments, available-for-sale 7,332,800
Inventory 1,468,476 918,651
Prepaid expenses and other assets 836,382 41,018
Total current assets 20,466,314 11,385,918
Long-term assets:    
Furniture and equipment, net 236,935 25,710
Patents, net 639,924 540,033
Restricted cash 2,741,054
Right-of-use asset 23,511,004
Other assets 163,533 2,174
Total long-term assets 27,292,450 567,917
Total Assets 47,758,764 11,953,835
Current liabilities:    
Accounts payable and accrued expenses 1,926,592 1,029,336
Notes payable, current 401,049 404,648
Operating lease liabilities 412,834
Royalty obligations 2,775,000 1,200,000
Total current liabilities 5,515,475 2,633,984
Long term liabilities:    
Notes payable 5,115,417 5,492,572
Operating lease liabilities 23,179,912
Convertible notes 1,300,000 1,300,000
Royalty obligations 163,000 2,638,000
Total long-term liabilities 29,758,329 9,430,572
Total liabilities 35,273,804 12,064,556
Commitments and Contingent Liabilities:
Redeemable preferred stock - subject to redemption: $0 par value; 20,000,000 shares authorized; 880,400 and 13,256,936 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 220,099 3,314,233
Stockholders’ Equity (Deficit):    
Common stock and additional paid-in-capital: $0 par value, 500,000,000 shares authorized; and 82,556,065 and 66,295,288 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 113,565,311 70,880,386
Accumulated deficit (101,191,633) (74,269,898)
Accumulated other comprehensive (loss) (108,817)
Total stockholders’ equity (deficit) 12,264,861 (3,389,512)
Non-controlling interest (35,442)
Total equity (deficit) 12,264,861 (3,424,954)
Total Liabilities and Stockholders’ Equity (Deficit) $ 47,758,764 $ 11,953,835